University of Münster
CRIS@UM
DE | EN

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study

Braess J, Amler S, Kreuzer K, Spiekermann K, Lindemann HW, Lengfelder E, Graeven U, Staib P, Ludwig W, Biersack H, Ko Y, Uppenkamp MJ, De Wit M, Korsten S, Peceny R, Gaska T, Schiel X, Behringer DM, Kiehl MG, Zinngrebe B, Meckenstock G, Roemer E, Medgenberg D, Spaeth-Schwalbe E, Massenkeil G, Hindahl H, Schwerdtfeger R, Trenn G, Sauerland C, Koch R, Lablans M, Faldum A, Görlich D, Bohlander SK, Schneider S, Dufour A, Buske C, Fiegl M, Subklewe M, Braess B, Unterhalt M, Baumgartner A, Wörmann B, Beelen D, Hiddemann W

Research article (journal) | Peer reviewed

Details about the publication

Journal: Leukemia
Volume: 32
Issue: 12
Page range: 2558-2571
Status: Published
Release year: 2018
Language in which the publication is written: English

Authors from the University of Münster

Faldum, Andreas
Institute of Biostatistics and Clinical Research (IBKF)
Görlich, Dennis
Institute of Biostatistics and Clinical Research (IBKF)
Koch, Raphael
Institute of Biostatistics and Clinical Research (IBKF)

Projects the publication originates from

A Randomized, Risk and Age Adapted Comparison of the Dose-Dense Regimen S-HAM (sequential high dose cytosine arabinoside and mitoxantrone) versus Standard… (AMLCG 2008)
Duration: 01/04/2009 - 31/03/2018
Funded by: Deutsche Krebshilfe e.V.
Type of project: Individual project